ATE206433T1 - Beta-schleifenähnliche verbindungen und deren verwendung als protease-inhibitoren - Google Patents
Beta-schleifenähnliche verbindungen und deren verwendung als protease-inhibitorenInfo
- Publication number
- ATE206433T1 ATE206433T1 AT96910566T AT96910566T ATE206433T1 AT E206433 T1 ATE206433 T1 AT E206433T1 AT 96910566 T AT96910566 T AT 96910566T AT 96910566 T AT96910566 T AT 96910566T AT E206433 T1 ATE206433 T1 AT E206433T1
- Authority
- AT
- Austria
- Prior art keywords
- beta
- compounds
- protease inhibitors
- sheet
- mhc
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title 1
- 229940042399 direct acting antivirals protease inhibitors Drugs 0.000 title 1
- 239000000137 peptide hydrolase inhibitor Substances 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 4
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 102000004169 proteins and genes Human genes 0.000 abstract 2
- 241001465754 Metazoa Species 0.000 abstract 1
- 102000035195 Peptidases Human genes 0.000 abstract 1
- 108091005804 Peptidases Proteins 0.000 abstract 1
- 239000004365 Protease Substances 0.000 abstract 1
- 102000001253 Protein Kinase Human genes 0.000 abstract 1
- 102000014400 SH2 domains Human genes 0.000 abstract 1
- 108050003452 SH2 domains Proteins 0.000 abstract 1
- 108091008874 T cell receptors Proteins 0.000 abstract 1
- 102000016266 T-Cell Antigen Receptors Human genes 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 108060006633 protein kinase Proteins 0.000 abstract 1
- 230000000087 stabilizing effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0202—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/005—Enzyme inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Transplantation (AREA)
- Cardiology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Crystallography & Structural Chemistry (AREA)
- Epidemiology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Heart & Thoracic Surgery (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Vascular Medicine (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicinal Preparation (AREA)
- Plural Heterocyclic Compounds (AREA)
- Cosmetics (AREA)
- Materials For Medical Uses (AREA)
- Paper (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US41051895A | 1995-03-24 | 1995-03-24 | |
| US54900695A | 1995-10-27 | 1995-10-27 | |
| PCT/US1996/004115 WO1996030396A1 (en) | 1995-03-24 | 1996-03-25 | β-SHEET MIMETICS AND USE THEREOF AS PROTEASE INHIBITORS |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE206433T1 true ATE206433T1 (de) | 2001-10-15 |
Family
ID=27021026
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT96910566T ATE206433T1 (de) | 1995-03-24 | 1996-03-25 | Beta-schleifenähnliche verbindungen und deren verwendung als protease-inhibitoren |
Country Status (8)
| Country | Link |
|---|---|
| EP (2) | EP0815123B1 (enExample) |
| JP (4) | JPH10508035A (enExample) |
| AT (1) | ATE206433T1 (enExample) |
| AU (2) | AU713530B2 (enExample) |
| CA (2) | CA2215695C (enExample) |
| DE (1) | DE69615671T2 (enExample) |
| ES (1) | ES2161354T3 (enExample) |
| WO (1) | WO1996030035A1 (enExample) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5840835A (en) * | 1995-10-30 | 1998-11-24 | Merck & Co., Inc. | Inhibitors of peptide binding to MHC class II proteins |
| US5817757A (en) * | 1995-10-30 | 1998-10-06 | Merck & Co., Inc. | Inhibitors of peptide binding to MHO class II proteins |
| AU7604196A (en) * | 1995-10-30 | 1997-05-22 | Merck & Co., Inc. | Novel inhibitors of peptide binding to mhc class ii proteins |
| US5719296A (en) * | 1995-10-30 | 1998-02-17 | Merck & Co., Inc. | Pseudopeptide lactam inhibitors of peptide binding to MHC class II proteins |
| GB9702377D0 (en) * | 1996-02-23 | 1997-03-26 | Zeneca Ltd | Peptide derivatives |
| NZ332347A (en) | 1996-06-07 | 2000-05-26 | Zeneca Ltd | Peptide derivatives containing a hydrophobic group, L-amino acid residues and modified L-amino acid residues |
| NZ332740A (en) | 1996-06-18 | 2000-05-26 | Warner Lambert Co | heterocyclically substituted carbamate or sulphonamide derivatives |
| ES2262184T3 (es) * | 1996-08-05 | 2006-11-16 | Myriad Genetics, Inc. | Utilizacion de mimeticos de hojas beta como inhibidores de proteasa y de kinasa o como inhibidores de factores de transcripcion. |
| EP1661566A3 (en) * | 1996-08-05 | 2008-04-16 | Myriad Genetics, Inc. | Use of beta-sheet mimetics as protease and kinase inhibitors and as inhibitors of transcription factors |
| GB9621836D0 (en) | 1996-10-19 | 1996-12-11 | Zeneca Ltd | Peptide compounds |
| GB9624562D0 (en) * | 1996-11-27 | 1997-01-15 | Zeneca Ltd | Peptide derivatives |
| GB9625865D0 (en) * | 1996-12-12 | 1997-01-29 | Zeneca Ltd | Peptides |
| ATE230414T1 (de) * | 1998-02-12 | 2003-01-15 | Molecumetics Ltd | Mimetika von beta-faltblatt und verfahren zur verwendung davon |
| US6323219B1 (en) | 1998-04-02 | 2001-11-27 | Ortho-Mcneil Pharmaceutical, Inc. | Methods for treating immunomediated inflammatory disorders |
| US8106094B2 (en) | 1998-07-06 | 2012-01-31 | Johnson & Johnson Consumer Companies, Inc. | Compositions and methods for treating skin conditions |
| US8093293B2 (en) | 1998-07-06 | 2012-01-10 | Johnson & Johnson Consumer Companies, Inc. | Methods for treating skin conditions |
| HUP0201295A3 (en) | 1999-01-27 | 2002-10-28 | Ortho Mcneil Pharm Inc | Peptidyl heterocyclic ketones useful as tryptase inhibitors |
| US7309688B2 (en) | 2000-10-27 | 2007-12-18 | Johnson & Johnson Consumer Companies | Topical anti-cancer compositions and methods of use thereof |
| WO2001064678A2 (en) * | 2000-02-29 | 2001-09-07 | Bristol-Myers Squibb Pharma Company | Inhibitors of hepatitis c virus ns3 protease |
| US8431550B2 (en) | 2000-10-27 | 2013-04-30 | Johnson & Johnson Consumer Companies, Inc. | Topical anti-cancer compositions and methods of use thereof |
| US7192615B2 (en) | 2001-02-28 | 2007-03-20 | J&J Consumer Companies, Inc. | Compositions containing legume products |
| US20120296067A1 (en) | 2010-02-03 | 2012-11-22 | Prism BioLab Co., Ltd. | Compound capable of binding to naturally occurring denatured protein, and method for screening for the compound |
| ES2819218T3 (es) | 2014-10-06 | 2021-04-15 | Cortexyme Inc | Inhibidores de lisina gingipaína |
| WO2017083433A1 (en) | 2015-11-09 | 2017-05-18 | Cortexyme, Inc. | Inhibitors of arginine gingipain |
| KR102780603B1 (ko) | 2016-09-16 | 2025-03-12 | 라이트하우스 파마슈티컬스, 인코포레이티드 | 리신 진지파인의 케톤 억제제 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA896851B (en) * | 1988-09-14 | 1990-06-27 | Hoffmann La Roche | Use of ace-inhibitors |
-
1996
- 1996-03-25 AU AU53729/96A patent/AU713530B2/en not_active Ceased
- 1996-03-25 JP JP8529594A patent/JPH10508035A/ja not_active Withdrawn
- 1996-03-25 CA CA002215695A patent/CA2215695C/en not_active Expired - Fee Related
- 1996-03-25 JP JP8529567A patent/JPH10508034A/ja active Pending
- 1996-03-25 EP EP96910566A patent/EP0815123B1/en not_active Expired - Lifetime
- 1996-03-25 AU AU53714/96A patent/AU712581B2/en not_active Ceased
- 1996-03-25 AT AT96910566T patent/ATE206433T1/de not_active IP Right Cessation
- 1996-03-25 EP EP96910547A patent/EP0817642A1/en not_active Withdrawn
- 1996-03-25 ES ES96910566T patent/ES2161354T3/es not_active Expired - Lifetime
- 1996-03-25 CA CA002215720A patent/CA2215720A1/en not_active Abandoned
- 1996-03-25 WO PCT/US1996/004044 patent/WO1996030035A1/en not_active Ceased
- 1996-03-25 DE DE69615671T patent/DE69615671T2/de not_active Expired - Fee Related
-
2000
- 2000-03-21 JP JP2000079170A patent/JP2000319295A/ja not_active Withdrawn
-
2004
- 2004-01-26 JP JP2004017703A patent/JP4152900B2/ja not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| EP0815123A1 (en) | 1998-01-07 |
| EP0815123B1 (en) | 2001-10-04 |
| JP2004131511A (ja) | 2004-04-30 |
| CA2215695C (en) | 2003-09-16 |
| JPH10508035A (ja) | 1998-08-04 |
| WO1996030035A1 (en) | 1996-10-03 |
| AU5371496A (en) | 1996-10-16 |
| AU712581B2 (en) | 1999-11-11 |
| CA2215695A1 (en) | 1996-10-03 |
| JP2000319295A (ja) | 2000-11-21 |
| ES2161354T3 (es) | 2001-12-01 |
| CA2215720A1 (en) | 1996-10-03 |
| JP4152900B2 (ja) | 2008-09-17 |
| DE69615671D1 (de) | 2001-11-08 |
| JPH10508034A (ja) | 1998-08-04 |
| DE69615671T2 (de) | 2002-08-08 |
| EP0817642A1 (en) | 1998-01-14 |
| AU713530B2 (en) | 1999-12-02 |
| AU5372996A (en) | 1996-10-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69615671D1 (de) | Beta-schleifenähnliche verbindungen und deren verwendung als protease-inhibitoren | |
| BR9914708A (pt) | Composição de matéria, dna, vetor de expressão, célula hospedeira, e, processo para preparar um composto farmacologicamente ativo | |
| MX9709265A (es) | Superantigenos modificados/quimericos y sus usos. | |
| DK0570493T3 (da) | Technetium-99m-mærkede polypeptider til billeddannelse. | |
| GB9720054D0 (en) | Biological products | |
| NO963371L (no) | Hematopoietisk protein samt materialer og fremgangsmåter for fremstilling av det | |
| WO2001083525A3 (en) | Modified peptides, comprising an fc domain, as therapeutic agents | |
| CY1107821T1 (el) | Πολυπεπτιδιο παραγοντα viii με ενεργοτητα παραγοντα viii:c | |
| Huse et al. | Semisynthesis of hyperphosphorylated type I TGFβ receptor: addressing the mechanism of kinase activation | |
| ATE532533T1 (de) | Von antikörpern abgeleitete vektoren für den transfer von substanzen in zellen | |
| DE69434384D1 (de) | Metalkomplexbildner | |
| DE69616303D1 (de) | O-malonyltyrosyl-verbindungen, o-malonyltyrosyl-verbindungen enthaltende peptide und ihre verwendung | |
| Wehofsky et al. | Programming of enzyme specificity by substrate mimetics: investigations on the Glu‐specific V8 protease reveals a novel general principle of biocatalysis | |
| Proctor et al. | Metabolism of peptide reporters in cell lysates and single cells | |
| ATE234284T1 (de) | Kondensierte isoindolone als proteinkinase c inhibitoren | |
| DE60330680D1 (de) | Transferrin-fusionsproteinbibliotheken | |
| DE60022879D1 (de) | Reporterverbindungen und verfahren zur auffindung von hochspezifische proteaseaktivität | |
| Xu et al. | Flexibility of interdomain contacts revealed by topological isomers of bivalent consolidated ligands to the dual Src homology domain SH (32) of abelson | |
| Schmeckpeper et al. | Detection of a possible precursor of immunoglobulin light chain in MOPC 41 A plasmacytoma cells | |
| ATE210465T1 (de) | Konjugat aus einem wirkstoff und einem nicht als körperfremd angesehenen, nativen protein | |
| ATE293163T1 (de) | Cyclin e spezifische konstrukte und komplexe | |
| DE69631624D1 (de) | Antikörper gegen menschliches restrictin | |
| DE69738945D1 (de) | Rken | |
| ATE128236T1 (de) | Verwendung von atelokollagen als festträger für die fixierung eines spezifischen fängers. | |
| DE69836096D1 (de) | Anti-idiotypische monoklonale antikörper, deren verwendung zur aktiven immuntherapie bösartiger tumoren, und zusammensetzungen die diese enthalten |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |